|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR |
1 Department of Physiology and Biophysics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1
2 Department of Molecular and Cellular Pharmacology, Nagoya City University, Nagoya 467-8603, Japan
3 Faculty of Kinesiology, University of Calgary, Alberta, Canada
| Abstract |
|---|
|
|
|---|
(Received 9 September 2006;
accepted after revision 22 December 2006;
first published online 4 January 2007)
Corresponding author W. R. Giles: Faculty of Kinesiology, University of Calgary, 2500 University Drive, Calgary, AB, Canada T2N 1N4. Email: wgiles{at}ucalgary.ca
| Introduction |
|---|
|
|
|---|
In addition to their role in maintaining the extracellular matrix, fibroblasts secrete a wide variety of hormonal factors, which then act as both autocrine and paracrine signals in the myocardium (Brilla et al. 1995; Ellmers et al. 2002). For example, cardiac fibroblasts secrete natriuretic peptides including brain natriuretic peptide and C-type natriuretic peptide (CNP). These peptides may have antifibrotic and antiproliferative functions in the heart (Tsuruda et al. 2002; Horio et al. 2003; Kapoun et al. 2004; Kawakami et al. 2004; Huntley et al. 2006).
In many different tissues, including the heart, the physiological effects of natriuretic peptides are initiated by the binding of two types of cell surface receptors. The natriuretic peptide type A and B receptors (NPR-A and NPR-B) include particulate guanylyl cyclase domains and, as a consequence, can alter intracellular cGMP levels when the peptide is bound to the receptor (Maack, 1992; Lucas et al. 2000). In contrast, the natriuretic peptide C receptor (NPR-C) is functionally linked to the G protein Gi, which inhibits adenylyl cyclase activity (Anand-Srivastava et al. 1996; Pagano & Anand-Srivastava, 2001; Zhou & Murthy, 2003). NPR-C, which may comprise up to 95% of the total NPR population (Maack, 1992), is known to bind all the natriuretic peptides with similar affinity (Levin et al. 1998) and is expressed in cardiac fibroblasts (Huntley et al. 2006).
Recently, we characterized a novel role for NPR-C in the CNP-mediated inhibition of L-type Ca2+ current in cardiac myocytes (Rose et al. 2003, 2004); however, the electrophysiological effects of CNP on the cardiac fibroblast have not been identified. As the fibroblast is considered a classic example of a non-excitable cell (Allessie et al. 2005), we reasoned that transient receptor potential (TRP) cation channel(s) may play a role in mediating electrophysiological effects of CNP. TRP channels are known to mediate influxes of ions, including Na+, Ca2+, K+ and Mg2+ (depending on the specific TRP channel), in a variety of cell types (Clapham et al. 2001; Clapham, 2003; Nilius et al. 2005).
Our findings demonstrate that (i) cardiac fibroblasts express non-selective cation channels that are potently activated by CNP, (ii) the effects of CNP are mediated by the NPR-C receptor and the activation of Gi, and (iii) the CNP/NPR-C-activated non-selective cation current is due to the activation of one or more TRPC cation channels.
| Methods |
|---|
|
|
|---|
All procedures used in this study were in compliance with the Canadian Council on Animal Care guidelines and were approved by the University of Calgary Animal Resource Centre.
Fibroblasts (and myocytes) were isolated from the ventricles of adult rats as previously described (Chilton et al. 2005). In summary, male Sprague-Dawley rats were anaesthetized using isoflurane inhalation so that no paw pinch reflex could be elicited, and then they were killed by cervical dislocation. Following this, the hearts were excised into ice-cold Tyrode solution containing (mM): 140 NaCl, 5.4 KCl, 1 CaCl2, 1 MgCl2, 10 Hepes, 5.5 glucose. The pH was adjusted to 7.4 with NaOH. The heart was Langendorff-perfused retrogradely via the aorta at 8 ml min1 with three successive solutions: (1) Tyrode solution for 5 min, (2) Ca2+-free Tyrode solution for 5 min, and (3) a Tyrode solution containing 4 µM CaCl2, 0.04 mg ml1 collagenase type II, and 0.004 mg ml1 protease XIV, for 8 min. The ventricles were then removed from the rest of the heart and cut into pieces approximately 1 mm3 in size. These were further digested in Tyrode solution containing 10 µM CaCl2, 1 mg ml1 collagenase type II, 0.1 mg ml1 protease XIV, and 0.5% bovine serum albumin, in a shaker bath at 37°C. Small samples of this mixture were observed periodically for the appearance of single myocytes and fibroblasts. It was typically after 3540 min in the shaker bath that aliquots of cell suspension were taken and placed in a KB solution consisting of (mM): 100 potassium glutamate, 10 potassium aspartate, 25 KCl, 10 KH2PO4, 2 MgSO4, 20 taurine, 5 creatine, 0.5 EGTA, 20 glucose, 5 Hepes, and 0.1% bovine serum albumin (pH adjusted to 7.2 with KOH). Cells were left in this solution for approximately 1 h before being used for electrophysiological studies. Fibroblasts were easily distinguished from myocytes by their much smaller size and more spherical shape (Chilton et al. 2005; Shibukawa et al. 2005).
Electrophysiology
The whole-cell configuration of the patch-clamp technique (Hamill et al. 1981) was used for voltage-clamp studies of single rat cardiac fibroblasts. Micropipettes were pulled from borosilicate glass (with filament, 1.5 mm o.d., 0.86 mm i.d.; Sutter Instrument Company) using a Flaming/Brown pipette puller (model P-87; Sutter Instrument Company). The resistance of these pipettes was 510 M
when filled with recording solution.
Microelectrodes were positioned with a hydraulic micromanipulator (SD Instruments) mounted on the stage of an inverted microscope (Nikon Diaphot). Seal resistances were 215 G
. Rupturing the cell membrane in the patch resulted in access resistances of 515 M
. The membrane capacitance of rat ventricular cardiac fibroblasts was small (415 pF). Series resistance compensation was not typically used since agonist-induced currents were relatively small and no transient responses were analysed in detail. Some of the data presented in Figs 1 and 2 were acquired using the perforated-patch-clamp technique. This was achieved by including amphotericin B (300 µg ml1) in the pipette solution. Results were not different from those obtained using whole-cell recordings and were therefore combined.
|
|
When attempting to measure L-type Ca2+ current (ICa(L)), fibroblasts were held at 80 mV. A prepulse to 50 mV for 250 ms, and then a test pulse to 0 mV for 250 ms were applied. The prepulse was to inactivate any other voltage-gated currents that may have been present, such as INa. To measure non-selective cation currents, fibroblasts were held at 0 mV. Ramp voltage clamp waveforms from 100 to +100 mV were applied over 1 s. In some experiments, step protocols were used. In these experiments, cells were held at 0 mV and then given a series of 500 ms voltage-clamp steps from 100 to +100 mV in 20 mV increments.
Solutions and drugs
The recording chamber was superfused at 2223°C with a modified Tyrode solution, containing the following (mM): 140 NaCl, 5.4 TEA-Cl, 2 CaCl2, 1 MgCl2, 10 Hepes, 1 glucose. The pH was adjusted to 7.4 using CsOH. The pipette solution contained the following (mM): 135 CsCl, 0.1 CaCl2, 10 EGTA, 4 MgATP, 1 MgCl2, 10 Hepes, 6.6 sodium phosphocreatine, and 0.3 GTP (sodium salt). The pH was adjusted to 7.4 with CsOH. The free Ca2+ concentration of this solution was nominally zero. All pharmacological compounds used in this study were purchased from Sigma Chemical Company, with the exception of CNP and the NPR-C-selective agonist, cANF, which were purchased from Peninsula Laboratories.
PCR
Cardiac fibroblasts were acutely isolated as described above and approximately 100 000 cells were collected using a cell sorter. Total RNA extraction and reverse-transcription from these fibroblasts were performed as previously reported (Ohya et al. 2002; Muraki et al. 2003). Reverse transcription (RT) was performed according to Invitrogen's protocol. In brief, total RNA (2 µg) and 200 ng of random hexamer in RNase-free H2O were heated for 10 min at 70°C and incubated for 10 min at 25°C for annealing. This sample was incubated for 60 min at 42°C using 150 units Superscript II RNase H reverse transcriptase (Invitrogen) in a solution (final volume 20 µl) that contained 50 mM Tris-HCl (pH 8.3), 40 mM KCl, 6 mM MgCl2, 1 mM DTT, and 1 mM individual dNTPs. After this RT procedure, the reaction mixture was added to 80 µl of distilled water and used for PCR. The PCR amplification profile was as follows: 15 s at 95°C and 60 s at 60°C for 1 min, according to a user protocol of AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA). The amplification was performed for 35 cycles. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were used to confirm that the products generated were representative of RNA. The amplified products were separated by electrophoresis on a 2.5% agarose/1x TAE (Tris, acetic acid, EDTA) gel, and the DNA bands were visualized by ethidium bromide staining. Each amplified product was sequenced by the chain termination method with an ABI PRISM 3100 genetic analyser (Applied Biosystems). Negative controls were carried out using water instead of reverse transcriptase, which resulted in no detectable signals in the PCR reaction. Brain cDNA was used as the positive control.
Real-time quantitative PCR was performed with the use of Syber Green chemistry on an ABI 7000 sequence detector (Applied Biosystems). Unknown quantities relative to the standard curve for a particular set of primers were calculated, yielding transcriptional quantification of gene products relative to the endogenous standard (GAPDH).
For the initial screening of TRP channel transcripts (Fig. 4) the following PCR primers were used: TRPC1 (NM_053558, 612712), amplicon = 101 bp; TRPC2 (NM_022638, 9911098), amplicon = 108 bp; TRPC3 (NM_021771, 14531557), amplicon = 105 bp; TRPC4 (NM_080396, 10091116), amplicon = 108 bp; TRPC5 (NM_080898, 1971399), amplicon = 103 bp; TRPC6 (NM_053559, 13861486), amplicon = 101 bp; TRPC7 (XM_225159, 15361638), amplicon = 103 bp; TRPV1 (NM_031982, 19762076), amplicon = 101 bp; TRPV2 (NM_017207, 18891989), amplicon = 101 bp; TRPV3 homologue (NW_047336, 11564671156520), amplicon = 104 bp; TRPV4 (NM_023970, 10971204), amplicon = 108 bp; TRPV5 (AF209196, 14731573), amplicon = 101 bp; TRPV6 (NM_053686, 18711971), amplicon = 101 bp; TRPM1 (XM_341869, 12201320) amplicon = 101 bp; TRPM3 (XM_342035, 517617), amplicon = 101 bp; TRPM4 (AB040807, 13341438), amplicon = 105 bp; TRPM5 (XM_344979, 26452745), amplicon = 101 bp; TRPM6 (XM_219747, 35423653), amplicon = 110 bp; TRPM7 homologue (NW_047658, 45266904526840), amplicon = 151 bp; TRPM8 (NM_134371, 18461951), amplicon = 106 bp; glyceraldehyde-3-phosphate dehydrogenase (GAPDH, NM_017008, 714817), amplicon = 104 bp.
|
|
|
Summary data for RT-PCR are presented as means ± S.E.M. The reproducibility of the RT-PCR measurements were evaluated using an analysis of variance (ANOVA) comparing repeat runs of samples. Mean values generated at individual time points were compared by Student's t test. Summary data for electrophysiological experiments are presented as means ± S.E.M. Data were analysed using either the paired Student's t test or an ANOVA with Dunnett's multiple comparisons procedure. In all instances, P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
When slow voltage ramps (100 to +100 mV over 1 s) were applied to ventricular fibroblasts from a holding potential of 0 mV, with all internal and external K+ replaced by Cs+ and TEA (see Methods), small inward and outward current changes were observed. Monitoring these currents in the absence of any pharmacological agonists revealed that a small weakly outwardly rectifying current with an apparent reversal potential near 0 mV was expressed in these fibroblasts (see Fig. 1 for representative examples, and summary data for the current properties in steady-state control conditions). On average, the maximum inward and outward current densities in the absence of any pharmacological compounds, measured at 100 and +100 mV, were 5.80 ± 0.8 and 7.68 ± 1.4 pA pF1 (see black bars in Fig. 1C, 1F and 1I for steady-state control current densities).
The ion permeation properties of this current (activated using voltage ramps) were examined in detail and these results are summarized in Fig. 1. To determine if the current was a chloride current, NaCl was replaced with NaCH3SO3, resulting in a low external Cl concentration. Representative currentvoltage (IV) curves and time-course data are presented in Fig. 1A and B, respectively. On average, there was no significant effect of lowering the external Cl concentration (Fig. 1C), indicating that the current is not a Cl current. The next set of experiments measured the effect of replacing external NaCl with NMDG-Cl. As illustrated in the representative IV curves (Fig. 1D) and time-course data (Fig. 1E), removing external Na+ markedly decreased inward currents (at negative potentials) without affecting outward currents. This effect was reversible upon return to normal external Na+ concentration. On average, maximum inward current was decreased from 3.9 ± 1.2 to 1.2 ± 0.9 pA pF1 (Fig. 1F), indicating that the current response is primarily due to inward Na+ movement at negative membrane potentials. The extracellular solution in which Na+ was replaced with NMDG+ still contained Ca2+ and Mg2+, which was likely to account for the remaining inward current. Finally, the effects of removing external Ca2+ and Mg2+ were evaluated. This manoeuvre consistently increased inward and outward currents and resulted in a more linear IV curve (Fig. 1G and H), an effect that was completely reversible upon return to normal divalent ion concentrations (Fig. 1H). On average, maximum inward and outward currents in basal conditions were 5.4 ± 0.5 and 7.1 ± 1.1 pA pF1. These values were significantly increased to 7.9 ± 0.8 and 10.0 ± 1.3 pA pF1 upon removal of external Ca2+ and Mg2+ (Fig. 1I). This effect of divalent cation removal suggests that divalent cations can block monovalent cation permeation in a voltage-dependent manner. This phenomenon may be responsible for the outward rectification properties of this current. Similar results have been reported for other non-selective cation ion channels (Prakriya & Lewis, 2002). Taken together, the data presented in Fig. 1 demonstrate that the current measured with voltage ramps in cardiac fibroblasts has the properties of a non-selective cation conductance (NSCC).
Effects of CNP on the NSCC in cardiac fibroblasts
Figure 2 illustrates the effects of CNP and the NPR-C selective agonist cANF on the NSCC identified in rat cardiac fibroblasts. Application of CNP (2 x 108 M) consistently resulted in the strong activation of the NSCC. The I-V relation continued to show weak outward rectification and an apparent reversal potential of approximately 0 mV in the presence of the agonist peptide (Fig. 2A). The time course of this effect of CNP is presented in Fig. 2B. Superfusion with Tyrode solution containing CNP resulted in a slow increase in peak inward and outward currents. This effect reached a steady state in approximately 300 s at 22°C. Washout of CNP (not shown) was typically very slow, as we have observed in our studies of CNP effects on ICa(L) in cardiac myocytes (Rose et al. 2003, 2004). However, when washout of CNP was continued for 15 min or longer, a partial return to control current levels was observed. On average, peak inward and outward currents were 3.8 ± 0.8 and 5.3 ± 0.2 pA pF1, respectively, in steady-state control conditions. Following the application of CNP, these values increased to 48.7 ± 7.2 and 128.8 ± 16.3 pA pF1 (Fig. 2G).
This same experimental protocol was repeated after cANF (2 x 108 M), which is a selective agonist for the NPR-C receptor subtype, was added to the superfusate. cANF does not bind to the NPR-A or NPR-B receptors, hence it cannot modulate intracellular cGMP levels (Anand-Srivastava et al. 1990). Rather, cANF binds to NPR-C and activates an inhibitory G protein, Gi (Pagano & Anand-Srivastava, 2001; Zhou & Murthy, 2003). Representative IV curves (Fig. 2C) and time-course data (Fig. 2D) demonstrate that the effects of cANF on the NSCC were indistinguishable from the effect of CNP. On average, peak inward and outward currents were 5.1 ± 0.7 and 5.6 ± 1.6 pA pF1 in control conditions. Following the application of cANF, these values increased to 42.0 ± 8.1 and 139.1 ± 14.3 pA pF1, respectively (Fig. 2G). There was no significant difference between the effects of CNP and the NPR-C agonist cANF on isolated cardiac fibroblasts. These findings suggest that this CNP effect is mediated by the NPR-C receptor. The responses of the CNP/cANF-activated NSCC to external Cl replacement, external Na+ replacement and external divalent cation removal were very similar to the responses shown in basal conditions in Fig. 1 (data not shown). This indicates that the outward rectification of the cANF-activated NSCC is due to a voltage-dependent block by divalent cations, as described for other non-selective currents (Nilius et al. 2000; Prakriya & Lewis, 2002).
Because NPR-C is known to signal via an inhibitory Gi protein, we tested the effects of carbachol (CCh; 1 x 105 M) (which also activates Gi proteins via muscarinic receptors) on the fibroblast NSCC. Representative IV curves (Fig. 2E) and time-course data (Fig. 2F) demonstrated that CCh was equally as effective as CNP or cANF in its ability to increase the fibroblast NSCC. On average, peak inward and outward currents were 5.0 ± 1.2 and 4.5 ± 1.8 pA pF1 in control conditions, and 32.8 ± 10.9 and 92.3 ± 12.1 pA pF1 following application of CCh (Fig. 2G). The effects of CNP, cANF and CCh on the NSCC in rat cardiac fibroblasts were not significantly different (P > 0.05).
Role of Gi in the activation of the NSCC by CNP and CCh
NPR-C-mediated natriuretic peptide effects, as well as the effects of CCh, are known to involve the activation of inhibitory Gi proteins (Wickman & Clapham, 1995; Anand-Srivastava et al. 1996). To confirm that this was the case in the activation of a NSCC in rat cardiac fibroblasts, suspensions of fibroblasts were pre-treated with pertussis toxin (PTX; 0.5 µg ml1) for a minimum of 3 h at 37°C in order to inactivate Gi/o proteins. Following PTX treatment, fibroblasts were superfused normally and treated with either cANF (to activate NPR-C) or CCh at the same concentrations as used previously. Representative IV curves and time-course data for cANF treatment are shown in Fig. 3A and B, respectively. In these conditions the ability of cANF to activate the NSCC was abolished. Normally, cANF increased the NSCC within approximately 300 s (see Fig. 2); however, in the presence of PTX, no effects of cANF were observed over 600 s of recording. Summary data (Fig. 3C) demonstrate that pre-treatment with PTX completely blocks the ability of cANF and CCh to activate the NSCC in rat cardiac fibroblasts. We noted also that fibroblasts from the same isolations that were not treated with PTX displayed normal responses to cANF and CCh (not shown).
|
Numerous members of the TRP family of ion channels are known to be non-selective in terms of their ion permeation properties (Clapham et al. 2001; Clapham, 2003). Because of this, we hypothesized that one or more TRP channels could be responsible for the NSCC in rat cardiac fibroblasts. RT-PCR was used to study the expression of TRP channel transcripts in these acutely isolated cardiac fibroblasts. As described in Methods, RNA was isolated from rat cardiac fibroblasts and probed using specific primers developed against rat TRP channel genes. RT-PCR data depicting ion channel transcripts from the TRPC (Fig. 4A), TRPV (Fig. 4B) and TRPM (Fig. 4C) subfamilies are presented. Note that mRNA from several TRP channels in each subfamily is expressed. In particular, TRPC2, TRPC3, TRPC5, TRPV2, TRPV6, TRPM4 and TRPM7 consistently showed significant levels of expression in acutely isolated cardiac fibroblasts.
Pharmacological inhibition of the cANF-activated NSCC
Figure 5 demonstrates the effects of three potent, but non-selective, compounds on the cANF-activated NSCC. In this study, Gd3+ (1 x 105 M), SKF 96365 (5 x 105 M) and 2-aminoethoxydiphenyl borate (2-APB; 1 x 104 M), were tested. Each of these compounds has been shown to block currents carried by a number of TRP channels (Merritt et al. 1990; Halaszovich et al. 2000; Ma et al. 2000, 2001; Trebak et al. 2002; Prakriya & Lewis, 2002, 2003; Hunton et al. 2004). Representative current recordings and the time-course data for the effects of cANF (used to selectively activate NPR-C) and subsequent application of Gd3+ (Fig. 5A and B), SKF 96363 (Fig. 5C and D) and 2-APB (Fig. 5E and F) illustrate that each compound can potently inhibit the cANF-activated NSCC in cardiac fibroblasts. Summary data are presented in Fig. 9. On average, Gd3+ significantly inhibited the cANF-activated current. This effect averaged from 52.5 ± 10.8 and 98.9 ± 16.1 pA pF1, in the inward and outward directions, to 16.6 ± 9.6 and 33.5 ± 15.5 pA pF1, respectively. SKF 96365 inhibited the inward and outward components of the cANF-activated current in ventricular fibroblasts from 55.3 ± 8.8 and 115.0 ± 11.8 pA pF1, to 18.5 ± 5.8 and 35.5 ± 10.5 pA pF1, respectively. Additional results showed that 2-APB significantly inhibited the cANF-activated current, reducing it from 47.1 ± 10.2 and 111.0 ± 14.2 pA pF1, in the inward and outward directions to 21.8 ± 9.3 and 37.6 ± 9.6 pA pF1, respectively,
|
|
Although initially not appreciated, it is now becoming clear that many TRP channels have time- and voltage-dependent activation properties that are responsible for the shape of the IV curves of these currents (Nilius et al. 2005). In many instances, it is an intrinsic voltage dependence that is responsible for the outward rectification properties of TRP channels (Nilius et al. 2003; Voets et al. 2004; Grimm et al. 2005), while in other cases a voltage-dependent block by divalent cations causes rectification of the IV curve (Nilius et al. 2000; Nadler et al. 2001; Prakriya & Lewis, 2002). Our next series of experiments investigated the time- and voltage-dependent properties of the cANF-activated TRP current in cardiac fibroblasts by utilizing voltage-clamp step protocols rather than voltage ramps.
Figure 6A illustrates a representative family of currents recorded in control conditions and following superfusion with cANF (2 x 108 M). Currents were recorded using 500 ms voltage clamp steps from 100 to +100 mV in 20 mV increments (see Fig. 6A, bottom). Note that the current changes in response to this protocol (in both control conditions and in the presence of cANF) did not show any measurable time dependence. They are essentially instantaneous. As shown in Fig. 6B the summary IV curves obtained from voltage-clamp steps are indistinguishable from those obtained using voltage ramps. On average, peak inward and outward currents in control conditions were 8.1 ± 4.9 and 19.5 ± 9.7 pA pF1, respectively. Application of cANF significantly increased these peak current values to 57.3 ± 18.6 and 146.9 ± 38.4 pA pF1 in the inward and outward directions. Note that these values are very similar to the average values for peak inward and outward currents obtained using voltage-ramp protocols (Fig. 2). As with voltage ramps, the cANF-activated NSCC shows weak outward rectification and reverses near 0 mV when studied with voltage-clamp step protocols.
|
Figure 6E illustrates the use of a voltage-clamp protocol consisting of a series of 500 ms voltage clamp steps from 100 to +100 mV in 20 mV increments followed by a 500 ms voltage-clamp step to 100 mV. This representative recording was done in the presence of cANF (2 x 108 M) in the same cell as Fig. 6A and C. The current response during the series of voltage-clamp steps from 100 to +100 mV and resulting IV curve (Fig. 6F) were unchanged from those in Fig. 6AD. Furthermore, there were no tail currents evident during the pulse to 100 mV. These results (Fig. 6C6F) demonstrate that the cANF-activated NSCC does not display intrinsic voltage sensitivity.
Role of phospholipase C in the activation of the NSCC by cANF
Although the biochemical and molecular mechanisms responsible for the activation of TRP channels are not completely understood, activation of phospholipase C (PLC) can be importantly involved, particularly for the TRPC subfamily. As such, several members of the TRPC subfamily are classified as receptor-operated channels and are linked to PLC activation (Clapham et al. 2001, 2003). Support for the involvement of PLC in the activation of a NSCC by CNP/NPR-C in acutely isolated cardiac fibroblasts is presented in Fig. 7. These results demonstrate the inhibitory effect of U73122 (5 x 106 M), a PLC antagonist (Kobrinsky et al. 2000; Cho et al. 2001), on the cANF-activated NSCC. The representative traces and time-course data are illustrated in Fig. 7A and B. On average, the maximum cANF-activated NSCC was significantly reduced by U73122 from 59.0 ± 16.1 and 129.6 ± 28.7 pA pF1 in the inward and outward directions to 20.6 ± 6.9 and 44.6 ± 12.7 pA pF1 respectively (see summary data in Fig. 9). As a control experiment for the effect of U73122 on the cANF-activated NSCC, we studied the effects of U73343 (5 x 106M). This compound is a non-functional analogue of U73122 that has no effect on PLC activity (Bian et al. 1998). Representative current recordings and time course data are presented in Fig. 7C and D. These results demonstrate that U73343 has no effect on the NSCC activated by cANF (see also summary data in Fig. 9).
|
isoform of PLC, following receptor-activated dissociation of the 
subunit of the G protein (Murthy & Makhlouf, 1999; Murthy et al. 2000; Zhou & Murthy, 2003). Our results support the hypothesis that PLC is an important signalling molecule in the NPR-C-mediated activation of a NSCC in the cardiac fibroblast. Involvement of TRPC cation channels in the activation of the NSCC
Our data demonstrates a voltage-dependent block by divalent cations, as opposed to an intrinsic voltage dependence (Fig. 6). This finding and the involvement of PLC (Fig. 7) are suggestive of a possible involvement of one or more TRPC channels in the activation of the NSCC by cANF. PCR analysis (Fig. 4) detected the expression of TRPC2, TRPC3 and TRPC5 transcripts (TRPC3 was most highly expressed) in acutely isolated cardiac fibroblasts. TRPC2 and TRPC3 are known to be directly activated by DAG (Hofmann et al. 1999; Lucas et al. 2003), which is a product of phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis catalysed by PLC. Based on this rationale, we tested the ability of 1-oleoyl-2-acetyl-sn-glycerol (OAG), which is a functional analogue of DAG, to mimic the effects of CNP and cANF on acutely isolated cardiac fibroblasts. Representative current recordings and time-course data are shown in Fig. 8A and B. OAG was included in the recording pipette at a concentration of 1 x 104 M so that it could enter the cell by diffusion under whole-cell recording conditions. Immediately upon rupture of the cell membrane, OAG entered the fibroblast and activated a current response that was indistinguishable from that of CNP or cANF. On average, OAG increased maximum inward and outward currents from 4.4 ± 0.6 and 8.0 ± 1.5 pA pF1 in control conditions (at time 0 s) to 50.3 ± 15.6 and 97.7 ± 27.2 pA pF1 (Fig. 8E).
|
A summary of the effects of selected pharmacological compounds on the cANF-activated non-selective cation current in acutely isolated rat ventricular fibroblasts is presented in Fig. 9.
To provide further support for the expression of TRPC channels in cardiac fibroblasts, we performed additional molecular analysis in which full-length transcripts of the three TRPC channels detected in our initial screen (shown in Fig. 4) were amplified by PCR. Specifically, three or four pairs of PCR primers were designed to cover the full coding regions of TRPC2, TRPC3 and TRPC5 in rat cardiac fibroblasts. For all PCR primers examined, the PCR fragments with the predicted lengths (summarized in Table 1 in Methods) were observed in rat cardiac fibroblasts (Fig. 10). These results confirm that rat ventricular express full-length transcripts for TRPC2, TRPC3, and TRPC5. The smaller transcripts amplified by some primer pairs in Fig. 10 were confirmed to have no similarity to TRPC channel transcripts.
| Discussion |
|---|
|
|
|---|
Our findings provide evidence that cardiac fibroblasts express a weakly outwardly rectifying NSCC that reverses at approximately 0 mV. These results also demonstrate that CNP, acting via the NPR-C receptor and the activation of Gi proteins, significantly potentiates this current. The cANF-activated NSCC is potently inhibited by several well-characterized, albeit non-selective, compounds, including Gd3+, SKF 96365 and 2-APB. The RT-PCR data in Figs 4 and 10 demonstrate that several TRP channel transcripts are expressed in these cardiac fibroblasts. The additional experimental results presented in Figs 58 support the conclusion that the NSCC current activated by CNP and cANF is carried at least in part by channels that are within the TRPC subfamily, particularly the DAG-activated TRPC channels. This conclusion is based on (i) the cANF-activated TRP current being blocked by PTX and the PLC antagonist U73122 (Clapham et al. 2001); (ii) activation of the current being mimicked by intracellular application of OAG, independently of PKC activity (Hofmann et al. 1999); and (iii) the outward rectification of the current being the result of a voltage-dependent block by divalent cations (the IV curve is linearized in divalent-free external solution) rather than an intrinsic voltage dependence (Nilius et al. 2005). Many TRPC channels are known to be activated by G-protein-coupled receptors and the PLC pathway, and they are therefore classified as receptor-operated cation channels (Clapham et al. 2001; Owsianik et al. 2006). Furthermore, TRPC2, TRPC3, TRPC6 and TRPC7 are known to be activated directly by DAG, independently of PKC phosphorylation (Hofmann et al. 1999; Lucas et al. 2003; Zufall et al. 2005). This direct effect of DAG on channel activity is a defining characteristic of these TRPC channels. The finding that TRPC2 and TRPC3 mRNAs are expressed in our acutely isolated cardiac fibroblasts leads to the conclusion that TRPC2 and/or TRPC3 may be activated by CNP and the NPR-C receptor. However, it is not possible, based on our experimental data alone, to conclude that TRPC2 and/or TRPC3 are the only ion channels responsible for the activation of the NSCC by CNP/NPR-C-mediated signalling in the cardiac fibroblast. Although the IV curve of the NSCC measured in this study bears significant similarities to the IV curve of heterologously overexpressed TRPC3 channels (Dietrich et al. 2003; Lee et al. 2003), it remains possible that the CNP-activated NSCC is carried by heteromultimeric and/or multiple channels with properties unique from those measured in expression systems (see discussion of limitations of this study below).
The activation of a NSCC by CNP can be mimicked by application of the NPR-C agonist, cANF. This finding strongly implicates an important functional role for this receptor subtype in this electrophysiological response. Although, in general, NPR-C has been assigned the role of a clearance receptor whose function is to modulate the circulating levels of natriuretic peptides available to bind to the NPR-A and NPR-B receptors (Levin et al. 1998), it is now known to be functionally linked to a Gi protein (Anand-Srivastava et al. 1996). Our data suggest that the activation of the NSCC current by CNP and the NPR-C receptor involves the activation of Gi and PLC (Figs 3 and 7). The 
subunits of G proteins are known to stimulate the
isoform of PLC (Katz et al. 1992; Barr et al. 2000). Moreover, dissociation of the heterotrimeric Gi protein specifically activated by NPR-C has been shown to lead to the stimulation of PLC by these 
subunits (Murthy & Makhlouf, 1999; Murthy et al. 2000; Zhou & Murthy, 2003). PLC catalyses the conversion of PIP2 into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Our results also demonstrated that OAG mimicked the effects of CNP and cANF on the NSCC (Fig. 8). Indeed, DAG is able to directly activate both TRPC2 and TRPC3 channels independently of PKC (Hofmann et al. 1999; Lucas et al. 2003). In summary, our findings support the hypothesis that CNP binds to the NPR-C receptor, activates a Gi protein, and the resulting liberation of 
subunits stimulates the conversion of PIP2 to DAG and IP3 by PLC
. DAG would then be able to directly activate TRPC cation channels in cardiac fibroblasts.
In humans, the TRPC2 gene is thought to be encoded by a pseudogene. In rodents, TRPC2 has been found to be highly localized to the vomeronasal organ where it functions in pheromone sensing and regulation of social behaviour (Zufall et al. 2005). If TRPC2 is in fact activated by CNP and NPR-C in cardiac fibroblasts, this would represent an important, but previously unrecognized, role for this ion channel in the fibroblast population of the heart. TRPC3 is known to be expressed at significant levels in cardiac myocytes and smooth muscle cells. This has led to speculation that this channel may be a candidate for a receptor-activated non-selective cation conductance in these locations (Clapham, 2003). As TRPC3 was the most highly expressed TRPC channel in acutely isolated cardiac fibroblasts, this channel may be a significant target of CNP/NPR-C signalling. Our molecular analysis (Figs 4 and 10) also detected the expression of TRPC5 transcript. TRPC5 is known to be activated by pertussis toxin sensitive G proteins and the PLC pathway (Xu et al. 2006); therefore, TRPC5 could also be involved in the CNP/NPR-C response. The IV curve of TRPC5, as measured in overexpression systems, shows rectification properties that differ significantly from the IV curves we have measured in cardiac fibroblasts, although this can change when the channel coassembles with other TRPC proteins (Strubing et al. 2003; Xu et al. 2006). Further molecular work will be required to define the precise role of different TRPC channels in the CNP response in cardiac fibroblasts.
In addition to TRPC2, TRPC3 and TRPC5, RT-PCR data revealed the expression of several other TRP channel transcripts in the cardiac fibroblast (Fig. 4). In particular, mRNA for TRPV2, TRPV6, TRPM4 and TRPM8 all showed significant expression levels. However, based on their pharmacological and electrophysiological properties these channels do not appear to be involved in the response to CNP in ventricular fibroblasts. TRPV2 is activated by 2-APB (Hu et al. 2004), whereas the CNP-activated TRP current is blocked by this compound. 2-APB is known to function as a consistent blocker of channels in the TRPC subfamily, including TRPC3 (Ma et al. 2000, 2001). TRPV6 is one of the most Ca2+-selective TRP channels and has a strongly inwardly rectifying IV curve (Bodding, 2005). These properties are very different from the current activated by CNP and cANF in ventricular fibroblasts. TRPM4 is activated by intracellular Ca2+, is permeable only to Na+, and shows intrinsic voltage dependence (Nilius et al. 2003; Ullrich et al. 2005). Our pipette solution contained 0.1 mM CaCl2 and 10 mM EGTA, making the free intracellular Ca2+ nominally 0 mM. Under these recording conditions, TRPM4 would not be activated. Finally, TRPM7 shows very strong outward rectification, is inactivated by hydrolysis of PIP2, and is strongly inhibited by carbachol via the activation of muscarinic receptors (Runnels et al. 2002). In contrast, the NSCC activated by CNP shows weak outward rectification properties, is directly activated by DAG (presumably following the hydrolysis of PIP2 by PLC), and is increased by carbachol following muscarinic receptor activation. It remains to be determined how these other TRP channels that were detected affect the physiology of the cardiac fibroblast and under what conditions they are modulated.
It is important to note that the present study did not investigate the possible contributions of the
i subunit of the G protein activated by NPR-C to the electrophysiological effects of CNP on the cardiac fibroblast. NPR-C is known to negatively regulate adenylyl cyclase activity and decrease cAMP via the
subunit of Gi (Pagano & Anand-Srivastava, 2001; Zhou & Murthy, 2003). Furthermore, other studies have identified a cAMP-dependent regulation of certain TRP channels, such as TRPM7 (Takezawa et al. 2004). Whether a similar pattern of regulation is occurring in the cardiac fibroblast via NPR-C effects on Gi activity remains to be investigated.
We note that in our experiments the effects of CNP were mimicked by CCh (Fig. 2). A previous study showed that the effects of muscarinic agonists were minimal in cultured rat cardiac fibroblasts (Meszaros et al. 2000); however, the role of muscarinic acetylcholine (ACH) receptors has not been studied in acutely isolated cardiac fibroblasts. Our data, which demonstrate a potent effect of CCh that is completely abolished by pertussis toxin, strongly indicate the expression of functional muscarinic receptors. Understanding muscarinic receptor signalling in cardiac fibroblasts will require additional study.
Limitations of this study
The biophysical characterization of TRP channels under physiological conditions is still incomplete. Moreover, the lack of specific pharmacological tools remains a major limitation to the study of TRP channels in native tissues (Clapham et al. 2001; Clapham, 2003). Although our electrophysiological and PCR data support the conclusion that the CNP/NPR-C-activated NSCC may involve TRPC2, TRPC3 and/or TRPC5 there are no specific blockers for these channels. It is for these reasons that many TRP channel studies employ the use of heterologous expression systems to study channel properties. Our experiments were conducted in acutely isolated cardiac fibroblasts. The results provide novel insights into the electrophysiological effects of CNP and NPR-C in these cells. Although the data in this study clearly suggest TRPC channels are involved in the NPR-C-mediated response to CNP, definitive conclusions regarding the precise molecular identity of the TRPC channel(s) which are modulated are not possible. Future studies will endeavour to use molecular methods to confirm the conclusions drawn from the electrophysiological data presented in this study.
Consideration must also be given to the possibility that the functional characteristics of TRPC homomers measured in overexpression systems may not represent all characteristics of currents expressed in native cells. This is because it is now apparent that several members of the TRPC subfamily can form heteromultimeric channels by interacting with each other (Dietrich et al. 2005a,b). For example, TRPC3 is known to interact and form heteromultimeric channels with TRPC6 (Hofmann et al. 2002; Bandyopadhyay et al. 2005). There is some evidence that TRPC2 and TRPC6 can also interact (Chu et al. 2004), although see Hofmann et al. (2002). Based on this, and on the fact that our PCR data indicate that several members of the TRPC subfamily are expressed in acutely isolated cardiac fibroblasts, it seems plausible that the current activated by CNP and the NPR-C receptor is carried by heteromultimeric TRPC channels. It is also possible that other ion channels are active during the voltage ramps used in this study, which could contribute to the current changes and resulting IV curves in this paper. RNA interference or dominant-negative strategies may prove useful in determining the precise contributions of specific ion channels to the CNP/NPR-C responses identified in this study (Maruyama et al. 2006).
A functional role for CNP in cardiac fibroblasts
Recently, we have described a novel NPR-C receptor mediated inhibition of ICa(L) in cardiomyocytes (Rose et al. 2003, 2004). When considered in conjunction with those findings, the results of the present study raise interesting questions about the role of CNP and the NPR-C receptor in paracrine signalling in the heart. In the myocyte population of the heart, ICa(L) is inhibited via NPR-C signalling. This effect is mediated by the
subunit of the Gi protein that is activated by NPR-C binding (Pagano & Anand-Srivastava, 2001; Rose et al. 2004). In the myocyte, Gi activation inhibits adenylyl cyclase and reduces cAMP, thus decreasing ICa(L). In contrast, in the fibroblast, CNP/NPR-C signalling activates a NSCC, which may include Ca2+ entry through TRPC channels (Owsianik et al. 2006) following the activation of PLC. This effect in the fibroblast appears to be mediated by the 
subunits of the same Gi protein activated by NPR-C. Clearly, the details of these CNP/NPR-C effects on myocytes and fibroblasts, and how they may interact with each other in the heart, warrant further investigation.
Natriuretic peptides, including CNP, are upregulated and highly expressed in the setting of heart failure (Wei et al. 1993; Richards, 2004). Natriuretic peptides are thought to exert antifibrotic effects during heart failure by altering the secretion of collagen, matrix metalloproteinases, and various hormonal factors by the cardiac fibroblast (Horio et al. 2003; Kapoun et al. 2004; Kawakami et al. 2004). Furthermore, natriuretic peptide effects on cardiac fibroblast proliferation appear to involve the NPR-C receptor (Huntley et al. 2006). Since our results indicate that cardiac fibroblasts do not express time- and voltage-gated Na+ or Ca2+ currents, TRP channels are likely to play a prominent role in regulating Na+ and Ca2+ entry into these cells. It is possible that the effects of CNP and the NPR-C receptor on TRPC currents in these cells may importantly regulate the secretory properties of the fibroblast.
In summary, our findings reveal a novel role for the NPR-C receptor in the cardiac fibroblast. CNP, acting via the NPR-C receptor, Gi, PLC activity, and the production of DAG, activates a NSCC, which may involve TRPC cation channels. As TRPC channels are known to mediate an influx of cations including Ca2+ (Clapham, 2003) this sequence of events may be an important mechanism in the regulation of the metabolic and secretory state of the fibroblast population in the heart.
| References |
|---|
|
|
|---|
Anand-Srivastava MB, Sairam MR & Cantin M (1990). Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem 265, 85668572.
Anand-Srivastava MB, Sehl PD & Lowe DG (1996). Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J Biol Chem 271, 1932419329.
Bandyopadhyay BC, Swaim WD, Liu X, Redman RS, Patterson RL & Ambudkar IS (2005). Apical localization of a functional TRPC3/TRPC6-Ca2+ signaling complex in polarized epithelial cells. Role in apical Ca2+ influx. J Biol Chem 280, 1290812916.
Barr AJ, Ali H, Haribabu B, Snyderman R & Smrcka AV (2000). Identification of a region at the N-terminus of phospholipase C
3 that interacts with G protein 
subunits. Biochemistry 39, 18001806.[CrossRef][Medline]
Baudino TA, Carver W, Giles W & Borg TK (2006). Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol 291, H1015H1026.
Bian JS, Zhang WM, Xia Q & Wong TM (1998). Phospholipase C inhibitors attenuate arrhythmias induced by 